Michael Bauer, MD, PhD

Review Article

Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression: Systematic Review and Network Meta-Analysis

April 22, 2015

Xinyu Zhou, Arun V. Ravindran, Bin Qin, et al

Original Research

Supraphysiologic Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Study

November 26, 2013

Thomas J. Stamm, Ute Lewitzka, Cathrin Sauer, et al

Letter to the Editor

Correction for "'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories"

October 15, 2011

Koen Demyttenaere, Anne Verhaeghen, Nicolas Dantchev, et al

Review Article

Quality of Reporting of Randomized Controlled Trials of Pharmacologic Treatment of Bipolar Disorders: A Systematic Review

January 25, 2011

Daniel Strech, Bettina Soltmann, Beate Weikert, et al

Original Research

Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials

August 10, 2010

Florian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al

Original Research

Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression: Results From the German Algorithm Project

July 13, 2010

Katja Wiethoff, Michael Bauer, Thomas C. Baghai, et al

Original Research

Quetiapine vs Lithium for Bipolar

January 26, 2010

Read a study comparing the efficacy and tolerability of quetiapine and lithium monotherapy with a placebo for a major depressive episode in bipolar disorder.

Allan H. Young, Susan L. McElroy, Michael Bauer, et al

Original Research

'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories

December 17, 2009

Koen Demyttenaere, Anne Verhaeghen, Nicolas Dantchev, et al

Original Research

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

April 7, 2009

Michael Bauer, Herman W. Pretorius, Eric L. Constant, et al

Original Research

Long-Term Effectiveness of Lithium in Bipolar Disorder: A Multicenter Investigation of Patients With Typical and Atypical Features

December 31, 2008

Anne Berghöfer, Martin Alda, Mazda Adli, et al

Original Research

Acceleration and Augmentation of Antidepressants With Lithium for Depressive Disorders: Two Meta-Analyses of Randomized, Placebo-Controlled Trials

June 15, 2007

Nicolas Andres Crossley, Michael Bauer

Original Research

Long-Term Combination Therapy Versus Monotherapy With Lithium and Carbamazepine in 46 Bipolar I Patients

February 15, 2005

Christopher Baethge, Ross J. Baldessarini, Kirsten Mathiske-Schmidt, et al

Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression: Systematic Review and Network Meta-Analysis

Supraphysiologic Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Correction for "'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories"

Quality of Reporting of Randomized Controlled Trials of Pharmacologic Treatment of Bipolar Disorders: A Systematic Review

Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials

Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression: Results From the German Algorithm Project

Quetiapine vs Lithium for Bipolar

'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

Long-Term Effectiveness of Lithium in Bipolar Disorder: A Multicenter Investigation of Patients With Typical and Atypical Features

Acceleration and Augmentation of Antidepressants With Lithium for Depressive Disorders: Two Meta-Analyses of Randomized, Placebo-Controlled Trials

Long-Term Combination Therapy Versus Monotherapy With Lithium and Carbamazepine in 46 Bipolar I Patients

ELSEWHERE:

FOLLOW US:

Michael Bauer, MD, PhD

Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression: Systematic Review and Network Meta-Analysis

Supraphysiologic Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Correction for "'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories"

Quality of Reporting of Randomized Controlled Trials of Pharmacologic Treatment of Bipolar Disorders: A Systematic Review

Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials

Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression: Results From the German Algorithm Project

Quetiapine vs Lithium for Bipolar

'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

Long-Term Effectiveness of Lithium in Bipolar Disorder: A Multicenter Investigation of Patients With Typical and Atypical Features

Acceleration and Augmentation of Antidepressants With Lithium for Depressive Disorders: Two Meta-Analyses of Randomized, Placebo-Controlled Trials

Long-Term Combination Therapy Versus Monotherapy With Lithium and Carbamazepine in 46 Bipolar I Patients

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles